Showing results (271-280 of 347) with videos related to
Sort By:
Pageof 35
European Journal of Endocrinology|June 13, 1998
Serum leptin levels in children and adolescents with insulin-dependent diabetes mellitus in relation to metabolic control and body mass indexW Kiess, M Anil, W F Blum, et al.Histochemistry|January 1, 1994
Colocalization of cytokeratin 18 and villin in type III alveolar cells (brush cells) of the rat lungM Kasper, D Höfer, J Woodcock-Mitchell, et al.Radiology|December 1, 1995
Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolizationC Bartolozzi, R Lencioni, D Caramella, et al.Cancer|November 15, 1995
Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patientsR Lencioni, C Bartolozzi, D Caramella, et al.Neurology|May 9, 2001
Increased familial risk of cluster headacheM Leone, M B Russell, A Rigamonti, et al.Clinical Neuropharmacology|June 9, 1998
The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's diseaseA E Schrag, D J Brooks, E Brunt, et al.Abdominal Imaging|May 27, 2004
Multidetector CT and virtual endoscopy in the evaluation of the esophagusS Mazzeo, D Caramella, A Gennai, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|July 19, 2001
The prolonged cortical silent period in patients with Huntington's diseaseN Modugno, A Currà, M Giovannelli, et al.Current Drug Targets. CNS and Neurological Disorders|May 29, 2003
Recent knowledge on molecular components of Lewy bodies discloses future therapeutic strategies in Parkinson's diseaseF Fornai, P Lenzi, M Gesi, et al.Neurology|August 3, 1999
A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson's disease. The 053 Study GroupA D Korczyn, E R Brunt, J P Larsen, et al.Pageof 35